Ekos has been around a long time in the business of making ultrasound devices to improve the treatment of cardiovascular disease. Now it’s getting some rewards for that investment of time and money.
The Bothell, WA-based company agreed to be acquired... Read more »
Back in January I got an invitation out of the blue to give a 1-hour talk at the Palo Alto Research Center—the Xerox-owned lab better known as PARC. The invitation was completely open-ended. The full extent of PARC’s guidance was... Read more »
Seattle-based Cardeas Pharma just raised a lot more cash to fight a big problem that hospitals wrestle with every day, and which they’d rather not say much about publicly.
Cardeas, the startup led by prolific drug developer Bruce Montgomery, has... Read more »
This week’s Seattle tech news roundup features a hefty venture round for mobile ad tracking startup HasOffers, the new STEM-focused chancellor of University of Washington Bothell, an Avanade study of social collaboration tools use in the enterprise, and a Seattle AWS... Read more »
Seattle-based Kineta has found some more support for its drug development work from an unlikely source—a group of oil traders.
The company said today it has raised an undisclosed amount of cash from Hydra, a group made up of 13 recently... Read more »
What are the most powerful forces affecting innovation and the economy? That is one of the key questions facing the nation as we inch our way out of the economic mire.
Juan Enriquez may not have all the answers, but he... Read more »
Tableau Software continued producing visually stunning stock charts during its second day of trading, shining a favorable light on both the Seattle tech industry, and on big data companies.
Shares of the company (NYSE: DATA) were nearing $60 at one... Read more »
NanoString Technologies just started selling its first diagnostic test after 10 years in business, and now it’s getting ready for another milestone—an initial public offering.
The Seattle-based company said today that it is seeking to raise as much as $86.3 million... Read more »
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
No question, traders in the stock market knew there was going to be an appetite for shares of data visualization provider Tableau Software. But that hunger for business-tech IPO stocks is even deeper than Tableau guessed.
Shares of the Seattle-based company (NYSE:... Read more »